$33.500
-0.744 (-2.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CSTL Prediction & Forecast by Similar Chart Analysis
Alphio's CSTL stock price prediction model matches the current Castle Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $32.62 (-2.63%). The 1-week path is $33.58 (+0.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Castle Biosciences Inc Stock?
Castle Biosciences Inc (CSTL) appears to be a good buy right now due to its strong revenue growth and positive outlook. The company reported Q2 2026 revenue of $103.5 million, a 20% increase year-over-year, and raised its full-year revenue guidance to between $365 million and $375 million. Additionally, the current RSI is at 56.23, suggesting that the stock is in a healthy momentum range. However, the main risk is the net loss of $2.1 million reported in Q2, which could impact investor sentiment if losses continue.
CSTL stock price ended at $33.50 on Friday, after losing -2.22%
Castle Biosciences Inc (CSTL) last closed at $33.5, losing -2.22%. These facts feed the 1-day and 1-week CSTL price prediction above.
Forecast Drivers
Castle Biosciences Inc (CSTL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CSTL, ranked by similarity.
Seasonality analysis for CSTL
Historically the probability of a positive August return for CSTL is 33.33%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CSTL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $17.34 | $20.29 | $23.62 | -39.43% |
| Sep 2026 | $12.03 | $16.79 | $16.89 | -49.89% |
| Oct 2026 | $19.10 | $20.00 | $20.37 | -40.29% |
| Nov 2026 | $19.65 | $20.03 | $23.69 | -40.22% |
| Dec 2026 | $12.86 | $16.23 | $18.34 | -51.57% |
In 2026, Castle Biosciences Inc (CSTL) is projected to range from $12.03 to $23.69.
Castle Biosciences Inc 2026 monthly forecast
In Aug 2026, Castle Biosciences Inc is projected to average $20.29, with a low of $17.34 and high of $23.62.
In Sep 2026, Castle Biosciences Inc is projected to average $16.79, with a low of $12.03 and high of $16.89.
In Oct 2026, Castle Biosciences Inc is projected to average $20.00, with a low of $19.10 and high of $20.37.
In Nov 2026, Castle Biosciences Inc is projected to average $20.03, with a low of $19.65 and high of $23.69.
In Dec 2026, Castle Biosciences Inc is projected to average $16.23, with a low of $12.86 and high of $18.34.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.